# Case 145: NAFLD at BMI 23 — The TOFI Liver

> The liver is the canary. By the time ALT moves, the metabolic fire has been burning for years.

**Domain:** NAFLD
**Signal:** Strong
**Evidence type:** Case Report
**Patient:** 34F, Bangladeshi-American, BMI 23
**Source:** Hepatology Communications 2024 — Younossi ZM, et al. (PMID: 37445892)
**Canonical URL:** https://zinda.health/cases/case-145-nafld-without-obesity-tofi-liver-south-asian

## Summary

A 34-year-old Bangladeshi-American woman with BMI 23 (deemed 'normal') presented for routine screening. Her ALT was 62 IU/L. MRI-PDFF revealed 18% liver fat — moderate steatosis. Despite a normal BMI, lipid panel, and fasting glucose, she had established non-alcoholic fatty liver disease driven by visceral and hepatic ectopic fat deposition. The thin-outside-fat-inside (TOFI) phenotype made visible.

## Presentation

Otherwise healthy SA woman presented for executive screening. No alcohol use, no medications, no family history of liver disease. BMI 23, waist circumference 82cm. LDL 118, HDL 51, triglycerides 138, fasting glucose 94, HbA1c 5.5%. ALT was elevated at 62 IU/L on routine bloods.

## Key Finding

MRI proton-density fat fraction showed hepatic fat fraction of 18% (normal <5%, NAFLD threshold >5.5%). Visceral fat area on MRI was 124 cm² — equivalent to a European with BMI 30. FibroScan kPa was 5.8 (early F1 fibrosis). Adiponectin was 4.2 µg/mL (low). She had biopsy-equivalent steatohepatitis without a single conventional risk factor flagging on standard screening.

## Intervention & Outcome

Initiated 16:8 time-restricted eating, resistance training 3x/week, and supplemented vitamin D and omega-3. At 9 months: liver fat fraction 6%, ALT 28, waist 76cm. BMI was unchanged at 23. Body composition shifted dramatically without weight change.

## Zinda Insight (Clinical Blindspot)

BMI 23 is not 'normal' for a South Asian woman who never exercises and eats refined carbs. Her liver was telling the story her scale couldn't. NAFLD in lean SAs is not a paradox — it is the predictable output of constrained subcutaneous fat capacity (Overflow Tank) plus low adiponectin. ALT >30 in any SA patient demands hepatic imaging, not reassurance.

## First Principles

When subcutaneous fat depots are saturated, lipid spills into ectopic sites: liver, pancreas, muscle, pericardium. Hepatic ectopic fat impairs insulin signaling locally, drives gluconeogenesis, and produces VLDL — the precursor to atherogenic small-dense LDL. The liver becomes a central organ of metabolic disease before any 'systemic' marker (glucose, LDL, BP) moves. ALT is the early warning antenna.


## Framework Concepts

- The Overflow Tank
- The Sick Fat Cell
- The Adiponectin Deficit

## Conditions

- NAFLD
- MASLD
- Hepatic Steatosis
- TOFI


## Clinical Q&A

### Q: What ALT cutoff should be used for South Asian women?

Standard upper limits (40 IU/L) were established in cohorts that included people with subclinical liver disease. Healthy ALT is closer to <19 in women and <30 in men. For SA patients, any ALT >25 in women or >30 in men warrants further investigation — typically FibroScan or MRI-PDFF rather than just repeating bloods.

### Q: Is weight loss the primary intervention for lean NAFLD?

No — body recomposition is. The goal is to expand subcutaneous adipose capacity (resistance training builds insulin-sensitive muscle that competes with liver for glucose disposal) and reduce visceral and hepatic fat (aerobic exercise + lower refined-carb intake). Pioglitazone has emerging evidence for lean NAFLD specifically. GLP-1 agonists are effective but should be considered carefully in lean patients.


## Patient-Facing Summary

### What Happened
A 34-year-old woman who looked completely healthy by every standard measure — normal weight, normal lab tests — turned out to have a fatty liver, the early stage of a serious condition. Her liver was 18% fat (it should be under 5%). She didn't drink alcohol. She wasn't 'overweight.' But her body was storing fat in her liver because there was nowhere else to put it.

### Why It Matters
Many South Asians look thin on the outside but have fat hidden inside their liver, around their organs, and inside their muscles. This is sometimes called 'TOFI' — Thin Outside, Fat Inside. The mirror lies to you. The bathroom scale lies to you. Only specific tests can reveal it.

### What You Can Do
If you are South Asian, ask for an ALT (liver enzyme) blood test annually starting in your 20s. If it's above 25 (women) or 30 (men), ask for a FibroScan or MRI to measure your liver fat. Build muscle through resistance training — muscle is the metabolic organ that protects you. Cut ultra-processed carbs (white rice, biscuits, sugary drinks) and prioritize protein.

### Questions to Ask Your Doctor
- What was my ALT on my last blood test, and is it ideal or just 'in range'?
- Should I have a FibroScan to measure liver fat?
- Could a DEXA scan show my body composition more accurately than BMI?
- Would a GLP-1 medication or pioglitazone help me?


## Citation

When citing this case, attribute as: "Zinda Research Case 145: NAFLD at BMI 23 — The TOFI Liver, https://zinda.health/cases/case-145-nafld-without-obesity-tofi-liver-south-asian, citing Hepatology Communications 2024 (PMID: 37445892)."